Scientech Research LLC Takes Position in GRAIL, Inc. $GRAL

Key Points

• Scientech Research LLC acquired 25,214 shares of GRAIL, Inc., valued at approximately $644,000, representing about 0.07% ownership of the company as of the latest SEC filing.
• GRAIL reported a loss of ($3.18) earnings per share for the most recent quarter, which was below analysts' expectations, along with a revenue of $35.54 million.
• Canaccord Genuity Group upgraded GRAIL's target price from $32.00 to $43.00, maintaining a "buy" rating, while the consensus rating remains "Hold" with a price target of $31.50.

Scientech Research LLC acquired a new position in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 25,214 shares of the company's stock, valued at approximately $644,000. Scientech Research LLC owned about 0.07% of GRAIL at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. NewEdge Advisors LLC grew its stake in GRAIL by 390.3% during the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock worth $45,000 after buying an additional 1,401 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock worth $76,000 after purchasing an additional 623 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of GRAIL by 61.0% in the first quarter. AQR Capital Management LLC now owns 1,337,163 shares of the company's stock worth $33,991,000 after purchasing an additional 506,440 shares in the last quarter. Royal Bank of Canada grew its stake in shares of GRAIL by 17.7% in the first quarter. Royal Bank of Canada now owns 88,082 shares of the company's stock worth $2,250,000 after purchasing an additional 13,264 shares in the last quarter. Finally, Quarry LP grew its stake in shares of GRAIL by 1,965.4% in the first quarter. Quarry LP now owns 2,148 shares of the company's stock worth $55,000 after purchasing an additional 2,044 shares in the last quarter.

GRAIL Stock Performance

Shares of NASDAQ:GRAL traded down $0.61 on Friday, hitting $38.04. The company's stock had a trading volume of 519,444 shares, compared to its average volume of 664,371. GRAIL, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of -2.90 and a beta of 3.20. The stock's 50-day moving average is $35.66 and its two-hundred day moving average is $35.43.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.14) by ($0.04). GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%.The business had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. Equities analysts expect that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Transactions at GRAIL

In other news, major shareholder Chun R. Ding sold 339,800 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total value of $16,830,294.00. Following the completion of the transaction, the insider owned 3,305,055 shares of the company's stock, valued at approximately $163,699,374.15. This represents a 9.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Aaron Freidin sold 8,000 shares of the company's stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the completion of the sale, the chief financial officer owned 286,020 shares of the company's stock, valued at approximately $11,134,758.60. This trade represents a 2.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 361,694 shares of company stock valued at $17,780,266.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.